Repligen Corp. (NASDAQ: RGEN) on November 20, 2023, started off the session at the price of $152.09, soaring 3.35% from the previous trading day. During the day, the shares moved up to $157.6604 and dropped to $150.665 before settling in for the closing price of $150.60. Within the past 52 weeks, RGEN’s price has moved between $110.45 and $200.98.
Annual sales at Healthcare sector company grew by 42.96% over the past five years. The company achieved an average annual earnings per share of -47.48%. With a float of $51.91 million, this company’s outstanding shares have now reached $55.56 million.
Let’s look at the performance matrix of the company that is accounted for 2025 employees. In terms of profitability, gross margin is +53.64, operating margin of +25.60, and the pretax margin is +27.34.
Repligen Corp. (RGEN) Insider Updates
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Repligen Corp. is 7.03%, while institutional ownership is 102.92%. The most recent insider transaction that took place on Nov 10, was worth 557,328. In this transaction an insider of this company sold 3,788 shares at a rate of $147.13, taking the stock ownership to the 28,787 shares. Before that another transaction happened on Aug 29, when Company’s Director sold 850 for $171.38, making the entire transaction worth $145,673. This insider now owns 83,741 shares in total.
Repligen Corp. (RGEN) Performance Highlights and Predictions
As on 9/29/2023, Multinational firm has announced its last quarter scores, in which it reported $0.23 earnings per share (EPS) for the period topping the consensus outlook (set at $0.17) by $0.06. This company achieved a net margin of +23.20 while generating a return on equity of 10.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -47.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.26% during the next five years compared to 35.07% growth over the previous five years of trading.
Repligen Corp. (NASDAQ: RGEN) Trading Performance Indicators
Repligen Corp. (RGEN) is currently performing well based on its current performance indicators. A quick ratio of 2.11 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.97. Likewise, its price to free cash flow for the trailing twelve months is 89.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.03, a number that is poised to hit 0.33 in the next quarter and is forecasted to reach 1.77 in one year’s time.
Technical Analysis of Repligen Corp. (RGEN)
Repligen Corp. (NASDAQ: RGEN) saw its 5-day average volume 0.57 million, a negative change from its year-to-date volume of 0.59 million. As of the previous 9 days, the stock’s Stochastic %D was 51.05%. Additionally, its Average True Range was 7.53.
During the past 100 days, Repligen Corp.’s (RGEN) raw stochastic average was set at 63.82%, which indicates a significant decrease from 81.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.04% in the past 14 days, which was higher than the 51.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $150.11, while its 200-day Moving Average is $162.04. Nevertheless, the first resistance level for the watch stands at $158.65 in the near term. At $161.65, the stock is likely to face the second major resistance level. The third major resistance level sits at $165.64. If the price goes on to break the first support level at $151.65, it is likely to go to the next support level at $147.66. Assuming the price breaks the second support level, the third support level stands at $144.65.
Repligen Corp. (NASDAQ: RGEN) Key Stats
Market capitalization of the company is 8.69 billion based on 55,832K outstanding shares. Right now, sales total 801,540 K and income totals 185,960 K. The company made 141,190 K in profit during its latest quarter, and 18,170 K in sales during its previous quarter.